Home › OpGen, Merck to Co-Develop Antibiotic Resistance Dx, Informatics

OpGen, Merck to Co-Develop Antibiotic Resistance Dx, Informatics

Nov 14, 2016

NEW YORK (GenomeWeb) – OpGen and Merck announced today that they will collaborate to develop rapid diagnostics and informatics tools for antibiotic resistance.

Under the terms of the deal, Merck will give OpGen access to its library of 200,000 bacterial pathogens in order to support OpGen's development of rapid DNA tests and a genomic database of antibiotic-resistant pathogens.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

What's Popular?

In Molecular Diagnostics

  1. Cancer Genetics Cancels Planned Merger With NovellusDx

  2. Black Women With Breast Cancer Fare Worse, TAILORx Analysis Confirms at SABCS

    Premium

  3. Mobidiag, Autobio Diagnostics to Form Joint Venture in China

  4. Guardant Health to Develop Blood-Based CDx for AstraZeneca Drugs

  5. Exosome Diagnostics Suing Former Employee for IP Theft

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.